Close

New drug for symptom control presented at symposium

Reading Time: < 1 minute Sharing information at the symposium is what it’s all about. Today, Randall Kaye, chief medical officer from Avanir Pharmaceuticals, chose the symposium to give a presentation on a newly approved FDA drug for emotional lability (uncontrollable laughter and crying) called Nueudexta. Emotional lability is a symptom that is experienced by some people living with MND. Nuedexta is actually…

Greetings from Orlando!

Reading Time: < 1 minute Fortunately, our flight over here was plain sailing, with no delays due to weather. However, with two of our group being nervous flyers, this didn’t matter! On our arrival to the hotel (which is magnificent!) we had a walkthrough of where the conference rooms and poster presentation room will be held in. The poster presentation…

Countdown to the symposium

Reading Time: 2 minutes We organise the International Symposium on ALS/MND every year and it is regarded by the global MND research and healthcare communities as the conference to hear about and discuss advances in their respective fields. In two weeks time, we’ll be in Orlando, Florida making our final preparations for this years’ three day conference that begins…